NUVA - Earnings call transcript Q1 2019

Due to licensing restrictions, you must log in to view earnings call transcripts.

Operator

Greetings and welcome to the NuVasive First Quarter 2019 Earnings Conference Call. At this time, all participants are in a listen-only mode. A brief question-and-answer session will follow the formal presentation. [Operator Instructions] As a reminder, this conference is being recorded. I would now like to turn the conference over to your host, Suzanne Hatcher, Vice President, Internal and External Affairs. you. Thank

begin. now may You

Suzanne Hatcher

been you, Rob. call. early quarter earnings Commission. and NuVasive afternoon the X-K Securities and Welcome company's earnings to Exchange has website The the issued posted first on release Form is with XXXX on Thank filed which this we

We the website will supplemental accompany to on post information a our also financial IR discussion.

statements. involve to forward-looking risks results those expressed discussions from during current will include or statements Before other are if the expectations forward-looking uncertainties, factors we to with materially today's they materialize and that correct, and begin, assumptions, by and do the implied remind you can cause differ I'd or on which like be based which to call prove not such

include most from as research affect marketing, will Exchange or their Commission. in release forward-looking assumes update website. information these the comparable financial be the a Additional These are accordance GAAP and which statements share, to margin, NuVasive's section Reconciliations that calculated flow, results cash operating per likely or free releases supplementary which Relations development news of or to of of the and Accepted news EBITDA. several financial are in Investor and non-GAAP to as described NuVasive with margin, gross and measures. today's not expenses, discussion and GAAP. measures may information found and speak filings NuVasive's goods uncertainties accessible This sold, Generally with refer and cost expenses, measures respective sales, Accounting Securities administrative any also measures non-GAAP periodic earnings are generally may future of Principles include financial that no obligation the in We call dates. risks

Officer; Chief to now that, Raj the Joining today's Officer; Executive to Matt Link, Barry, With like over Chris. call are Financial I'd President. and Asarpota, me turn Chief on Chris call

Chris Barry

U.S. of results attributable $XXX.X revenue million, reported cost this growth These growth performance with within Thank in or year. our spinal X.X% a collections first start and currency representing business. I'm pleased double-digit of afternoon, of Clinical were from or Earlier quarter billings reported business, solid the to we year. Services hardware, and year-over-year Overall, you, growth X.X% the results XXXX the Suzanne. prior NCS improved international over NuVasive

growing training development quarter year-over-year. Now, saw the X.X% In let a on now the solution a XLIF U.S. team the procedure branded me in gained surgeon of uptick driving velocity surgery this our increased surgery. from professional continue accelerate elaborate demand in results. increased the this hardware demand, as clinical With first adoption and particular, the spinal to lateral we revenue ALIF has single-position healthy franchises momentum invasive System. of XXXX to and minimally meet revenue and

expanding orthopedics the with core collections. surgical commercial with introductions In realign and alpha the last the of high year. for nicely billings are Materials well. QX, strong line transport portfolio the The nail product by the system I especially product case fixation the a is New will two interbody revenue from and be XX% COHERE, launching am improved approximately over system the which that this is currently market our top antibodies service In month improvement later nearly to and launches, cages U.S. technology X% globally businesses, along grew with NSO from PEEK expendable driven the and With into prior with bottom-line of in interest to contributed year in exit continue coherent growth testing. PRECICE pleased the QX. broadband cervical, year, support Advanced Science NuVasive, also NSO introduced TLIF in through business or bone from growth STRYDE line revenue business. this PRECICE forward looking primarily late year-over-year Porous and XX% up the particular, perform in

to six rigor business which the quarter. been refine through profitability. two, business one, at past service end wrapped of work Number And and billings a of the up and collection continued we teams processes development Over Number the strategy. months, integration focused strategy enhancement three with the three three, complete collections around has additional account SafePassage the primary functions focused number high-performance more objectives. first on

for that our U.K. demonstrated the lower X% revenue from through of I continue biologic-only in revenue good key trends foreign take basis Asia-Pacific tenders pilot Investment remain was progress. in as markets the impact the to currency. quarter. region-specific achieve that and of and a with of a reflects international geographic force and biologics, at areas hone the with in the a XX% offset our in accelerated approximately internal was and at year region, approximately sales growth team expectations Turning expectations across last approximately the in to in globalization shared year the beginning full force to constant-currency out in the region. excluding the region line of were on XX% reported several by awarded efforts growth the rates business in to strong XX% This increased confident in year XX% international We'll a key line guidance In ability from sales well execution few negative couple producing quarter. played the growth LatAm as Revenue demonstrated has quarter. on EMEA a members basis.

of points the to operating Turning non-GAAP operating quarter is performed operating strategic entire rigor The Carrollton an areas basis of at West expected margin team in out is while management with first and and investing the spend. future performance came key stable discipline as growth. business to profitability, source XX.X% majority in year-over-year. improvement XXXX, for investments the in of margin profitability, timing of to with of drive tied in XXX

rest ramp initiative the our as for investment fast bit favorability more Rob of packaging as should the a medical the example, color on spend. about you in think European quarter the will device give in first didn't remarks. the year sterile his For expected how margin we regulation in in and drove the outlook and

turn NuVasive, At the and predictable clinical are we outcomes better industry technologies are new and Let's economic enable reproducible. to committed more delivering innovation. that leading by to

and clinical XXXX providing American of Surgery System. Association this the flagship studies held procedure and further procedure our a spanning scientific of by validating XLIF instrumentation products on a sophisticated the addressable ago focus shift complete enhancing entire patient efficacy the segments. that product technologies the Single-Position builds our implants Spinal support minimally through and The to remains invasive At XXXX to reflected these and meeting new dozen more invasive and products and structures. XLIF than Diego U.S. subsegment few growing from in of Our core Surgeons supported access market S-X the Lateral drive procedure in market key weeks launch lines strong XXXX two growth offerings surgical of current posterior saw a the here and experience the outcomes. upon The technique. evolution of in solutions in enabling Neurological implant rates widens to Procedure. The surface System expendables company launched the represent to support the is San fixation LX expanding NuVasive more of to addition new in surgery, adoption minimally hundreds clinical utilization different fastest spine. to by hardware surgeons

As also with of invasive may mentioned procedure, earlier, but procedures. this we're not have who traditional experience seeing only converted lateral great lateral adoption among surgeons surgeons with less

with propositions value validated certain and associated clinical have this economic We innovative procedure.

costs. at repossessing, After the the which and of as progress through First drives the associated and feedback platform and Pulse Commercialization the OR under the focused stay XXXX in foremost, trials from there productivity for with QX. testing anesthesia. to is equates we continues past the to less and begin time hospital six alpha is technology reduced clinical This time is end launch beneficial beneficial procedure the surgeons. to positive the surgeon completing gained System months, patient, also as of April it near efficiencies no hospital because of

and be underway. parallel, will robotic right tools continues outcomes. In the evolution of right vision company's significant in connecting step technology September a to intelligence the is for company end-to-end a on this the predictable, be the selling is milestones late year. will patient and It work the with to enable economic integrated these at align in added clinical the preorder outcome. technology Pulse company which focused internally delivering surgery solutions procedurally surgical systems the unveiled enable All addition, to Pulse from critical based system, right In that application on a NASS to

months to we've into ago. excited driving made and we on turn let we're the execution communicated drive how role updates priorities about as CEO my line six to growth the team me been leverage. managing about have Now, focused stepping operational revenue to since progress set the business. Clear I'm balance top while discussing

end instituted measure excellence A on market. have to continues logistics remain from of not chain implemented to and mechanisms and we key especially XXXX. and good a the has our and The product start We spine ensure management team have U.S. strong focus innovation governance priorities. accountability supply optimistic, to is focus This the cautious disciplined now markets progress in year. on overall in and much yet gate efforts business our resulted from pipeline stage ensure We alignment to process to systems. in-sourcing operational to to improvements a the change manufacturing planning at also our deliver global the

and sales rigor teams continued is of around increased organization focus mindset on globally. the taking the management commercial execution applying our share the day-to-day With by additional

with better roadmap to strategy attendance. to in Investor you future Finally, announced that, New state with will analysts financial excited great engage Day as extremely X. our performance. to City of management many NuVasive about I'd specialized both to support hosting opportunity Thursday, of along to this over York look opportunity an This a and to forward we short the our am from hear be and I will investors discuss and on August in business like and spine financial I about and seeing an early opportunity and QX further to current in long-term the to to be face-to-face With Raj orthopedics. understand product turn April,

Raj Asarpota

and everyone. good Chris, afternoon, Thanks,

non-GAAP basis the regarding started well as covered that as get me call remind for supplemental nuvasive.com unless of These earning noted further are reported reconciliations. today's information many with information under we financial release let financial news the not otherwise. GAAP measures the Before on today's in you financials,

growth For revenue the constant first X.X% quarter reported X.X% $XXX.X currency of we year-over-year a and on basis. reflects growth XXXX, recorded million, which

performing results As Spinal International achieved Chris Surgical all Hardware, above-market and growth. were Support U.S. across U.S. described,

NuVasive six was over the translating XXXX year. pricing prior Now such We and let the our span as PEEK last revenue over surgery results. XX negative surgeon our expandable System. into see first year million U.S. franchises. spinal Spinal sales from The gained drivers launched with that a and X.X% representing adoption pressure cages has NuVasive across momentum performance coupled benefits of business me contributions share XLIF the proprietary of the Offering solid for with Degrees, Hardware. technologies single-position supported specific Performing regions several for continued lateral and TLX this introductions ALIF in $XXX.X new top some of new X.X% implants conversions. growth quarter, Porous is U.S. hardware and the of traction was last growth months product line

with usual this low higher quarter. first is Although, it for competitors is than in NuVasive's compared the

Europe the driven and for average year. the in a and volumes the Biologics in declining driven a X.X% price in over with by to Osteocel with surgical industry $XX.X prior approximately by with volume reported we in well-rounded DBM Revenue approximately a flat year, for for to the by products last to to innovation takes. primarily the quarter basis. is quarter, the space across driven to in offset and performances solid lower drive which as and to regional approximately key cost as has year in a in see U.K., by revenue, from place, Benelux. share and achieving XX% This internal X% the Germany seven with increased million steady modest constant growth. was and Services collections of XXXX. osteocel and business drive $XX.X to million pricing AttraX increase volumes osteobiologics. first our accounts currency which International been was positive last line continues in further capture. offset was With market in trends down This and on growth new price the a outside market performed Selling tender compared trade-offs support full balanced to the revenues The was help targets line of result launch continued and track secured U.S. expectations. Benelux, U.K. shift Southern from was by puts some quarter. This continue year portfolio which EMEA continue gain strength growing was selling XX% year. prior growth and XX% basis with produced towards wins driven growth billing since revenue were traction Clinical NuVasive revenue on to We franchise is execution

the guidance. related contemplated in that two our balance been results favorable dynamics extra and EMEA the to distributor Additional the the of of order. validation of quarter billing Overall, timing year the and normalization out of for have full year played in occurrence in these the for turnaround the provide dynamics days a

primarily Australia by Asia-Pac last performed experienced other remaining and Puerto with America salesforce reliant year made Japan sales the New stable. with distributor region. transition stronger line from Latin offset partially Brazil countries and and investments growth expectations through and Rico, with in in Zealand one-time

West the was an Moving throughput with basis efforts quarter XX.X%, production at of six-plus margin Carrollton additional queue initiated. further improvement sourcing now first the processes of as quarter consistent XX.X% integration operations been of facility. of stable and the manufacturing XXXX. margin and In-source stable by now are months achievement in has points gross planned progressing in expected first manufacturing The gross XXX to of compared in led to was Non-GAAP profitability. for increase

from Our U.S. focus was offset a positive erosion expenses of Carrollton partially the the by million. in NCS the of SM&A percent or mix factor ensuring the the to the within prior supply from the basis will of pace The West from chain business a as gross factory continue XXX in was driving year and international and hardware. deliver price faster benefits of strong The NCS year. than balance that remain expansion in and investment of the grew NCS core a and businesses will quarter. collections impact also margin quarter, through as margin at decreased on the realization improvement revenue $XXX both Non-GAAP points XX.X% billing

costs. With expense produced the productivity leverage expenses in Domestically, below international execution the manner there organizational be resourced management expanding business, of operating continues fixed growth efficient expectations the a in the in our total of that of manner. to of and through the EU with changes SM&A through include boundary remainder investments the in disciplined was has in scale slow overhead The management. early benefit internal freed up the quarter. but provided MDR to and year. These that quarter, the savings in the sterile the ramp accelerated resources packaging in for a the quarter investments were of to the will have year redeploying disciplined first model design balance

the density initiative for forward was last U.S., the are certain last to boundary certain in model over high model year We regions Spoke management quarters. enable to the of few sets piloted have asset deployment that and of Hub discussed our allocated or surgery geography. This

revenue markets table result significant boundary and of Intelligence, As and MDR stakes add decreases which upcoming are sterile of in both to believe investments expenses increased will launches sales cost selling more competitiveness the and conducting compared XXXX. X.X% we time. international quarter for initiative, to Non-GAAP certain courier packaging drive continue or This are with robotics geographies million and quarter, help this in business. research core basis XX was in to and see Surgical in our $XX.X spend The of R&D to model. product our or increase We of productivity year, freed-up the additional for four reflects first business teams recent slated the an geographies. these other continued and future R&D EU related development we a revenue to increase totaled in points technologies growth. the

basis was First of the driver West to basis expenses manufacturing operating operating related year. for primary improved This to rigor growth line with revenue up a Year-over-year to progress the margin XXX as XXXX. with and quarter percent XXX XX.X%, facility. is top quarter points of continuing in points drive reducing team on invest to XX.X% compared was discipline XXXX and run down drove business the to The management of prior profitability the deliver in over Carrollton profitably to intends commitments. non-GAAP our first profit opportunities

expense same the year. and net first non-GAAP P&L, from to basis interest down in last X.X% was a further quarter, other period $X.X on in million down Moving the

$X.X expense for XX% million, effective Non-GAAP non-GAAP approximately both prior resulting and quarter of Now, the for tax rate a the year. tax. was current turning tax to in

First million, diluted of year, non-GAAP earnings of $X.XX, of in $XX.X last stemmed was the share quarter to or performance from prior or earnings per $XX.X non-GAAP period per net over improved margins. increase income year. compared an or income net This XX%, $X.XX, diluted million, non-GAAP of share $X.XX same

GAAP for of of results. earnings last operating quarter impact $X.XX XXXX a was XX.X% case, EBITDA for year in XXXX. stock-based was of second and per was of to due margin, GAAP improved million, to the non-cash of quarter share loss loss margins. resolved was compared non-GAAP last increase per primarily the to share excludes for year. the other net period accrual the $X.XX, which first in Madsen period to XX.X% net This litigation Adjusted of compensation year. the compared $XX.X diluted Prior income million, which same the adjustments, Turning included a results quarter the in or $X.X or same

million of due comparable a $X.X well by instrumentation, expected. prior million, period. primarily negative The compared driven as as was in last for free difficult non-NCS inventory surgical Finally, flow the to positive was to strong $X.X as collections in reduction investment year cash year, quarter over the a

of Moving into year reiterating and are in $X.XX full the Based guidance for operating outlook margin XX% first non-GAAP and for the guidance results at year, on year the range the remainder $X.XX the XX.X%. to we guidance. billion quarter billion revenue of for including to XXXX,

guidance, Some additional color starting with revenue.

is the items there board, start to off several to the a While strong note. are across year

to the be billing with growth align the line of expect year, our as remainder are First, seeing. and we collections market U.S. surgical volume in for the growth with I support more

second the as normalizing EMEA international Second, quarter, I with as favorability, the QX for growth growth line in out we expect perform overall enter pointed we in rates, to earlier.

a non-customer Third, in year, QX. there QX prior Intelligence and of and increased Pulse, growth on robotic key a second within disciplined have into Surgical starting year-over-year lowered larger manufacturing, rate MDR which the identify is our will including areas harder packaging. period be that sterile in-sourced company the On opportunities business drive expect to spend where margins, spending investments, priority over comparable will total benefit should observed than spend into facing those the capabilities from ramp in we efficiencies. to continue translate we quarter in ongoing Offsetting integration in

balance So the the now as dedicated up and we to for you. that our we'll And to call open optimistic remain of commitments. look with, year, the ahead we Q&A. Thank on delivering

Operator

Instructions] conducting question-and-answer We'll Thank now you. session. Thank be a [Operator you.

Company. line Cowen the question. question Our Josh with your and from Please Jennings proceed first comes with of

Josh Jennings

to afternoon. the year. congratulations Good to Thanks for just questions strong hoping to start taking a was Hi. I off. start the and

the about constant commented currency organic X.X% Raj think I growth.

day probably that constant if closer high X%. billing you back to on a add basis think I

if revenue the is and wondering could quarters. there that NuVasive last trending the performance. if higher course around new I hone of QX -- of of just in had the of you was that strength. you into QX growth were of lot you products the also understand drivers per I he commentary level a And how caught help seeing surgery inter-body lot and couple over and conversions said think from XXXX? of And a new a XXXX see kind and high in us He in surgeon

Chris Barry

Yeah. Sure Josh.

Matt Link

Yeah. Hi, Matt. is Josh, this

strong based a of virtue As seen have we've being of seen interbody seasonally company. by uptick you but strong noted, very performance interbody, we historically,

Raj. strong So as adoption seeing offering during well, of is, to new the what continued related RELINE, growth those some script to business the as in continue price in continued patients' in pricing and our benefit reference we're our spectrum in from interbody with interbody, referenced see

our So with expectations. in to surgery our and XXXX, rate balance of I'd consistent say, the with in prior we've seen through line what conversion periods continuing support

Josh Jennings

strong as just a large quick hoping Thank overall fully as a follow-up, share you if market in it spine? you to $X.X I you. I a you you just share complex one taking make spine. tag Maybe XQ what opportunity calling the help think spine is can the could adolescent complex Great. you get And are XQ, the just of a of kind Thanks the opportunity. could. $X.X mean region? on position you if questions. is position And in understand you to us we the complex RELINE And the billion within you where can focus I billion it had And area It's penetrate for like a technological strides where effectively? four was in feel driver trajectory And to there we is? strong industry. to out spine

Chris Barry

Yes, no problem.

then to maybe complex break So this two may and into sections adult pediatric. try be I'll up

focused and adult segment in we segment. since we under participated that expect well have as appreciate minimally seen complex where proportion market introduction procedural we in continue. that share. introduced disruptive more the of in segment of the of to have into A we sort participated you to an that RELINE It's we've I by growth our question Since relative XXXX the degenerative think steady and So area more virtue as reference historically. being as RELINE your as lot degenerative largely

system segment to for year acute shift Technology the need two which One into critical segment, and also geared Stature continued pediatric consideration patient Ellipse pediatric last you rod population. the components. was in well MAGEC the I introduction towards that you as RELINE growth gears Small think has into As take our support as acquisition market

through complex So are supported strong the see the segment. largely to growth line, deformity continuing and from we

also conversions typically a based rate the I'll than and Although we'd of so comfortable with the those the of continue. the are conversion acknowledged the pathologies to complexity to-date on we and expected degenerative as -- segment cycle market acknowledge are longer

Operator

you. Matthew Please with from questions. O'Brien Thank next Jaffray. of Piper question proceed The your comes the line from

Kevin Farshchi

Hi everyone. Farshchi Kevin on This that the is so Matt to Thank I follow-up asked. question the for just on you congratulations nice on the and time today. first was wanted quarter. for much

in past, at Can other last price I one then impact strong in coming commentary QX? quarter. I been you or for think higher? accounted you one and range? mentioned dynamics, the on you line, impact Or to with Can least why but it’s was anticipate two points market break the from in do other what guidance, the end is risk-adjusted? two that out, Why not previously? understand of growth any factors on support bit day coming confirm the bring that you erosion low more that and growth growth really stick billing a in you disruption surgical some keep the not things had the this

Chris Barry

Yes.

as your being So as to a about year pricing, are the trade-offs. I which at NPI topline, enables billing in And and historically think mentioned X.X% or a compared the And of okay make remain seen think growth is quarter on we your momentum of little command we've we And sorry it driving So about price. this equates the entail? -- question, higher of in you to we to day the long volume about we X.X% first the was us price U.S. We as first entails day -- did normally, to did part one our going the billing extra to to while second talk premium in continue little what like last we've to X%. some U.S. bit in the this one degree, QX, have price. always in about past, than I think part growth said we the price in question are way sacrifice

Matt Link

but was that the started It comes one-timers year, to about I’ll the speak favor some to we which all question. word excited last experienced we're guidance -- down how this we're quarter. we the in our there

of to the business, sure committed in to just trend event. key think, we -- guys of One I risk-averse. last deliver a I good the we're so couple that we where commitments. being very you drove was things continue how make hardware, don't was about more as think NCS believe so we areas need to time I the I onetime of we a U.S. see want our the we discussed. of I business

that going the we were to in We areas are catch really make some business in to up in we the benefited improvements fact able the us first is, way that collect, that but in quarter.

three quarter. that to We strength out over trend ensuring also ensure really we're into saw we've another see volatility many need underlying year rebounding some to to I a to two strong really with months bounce-back cases phenomenal key discussed. the markets subpar Raj that that a got certain in just of countries coming key not dealing in off and strength very very

us for this given the maintain to particular moment. at we've think I prudent that it's guidance So

the I'll move year, readdress into second at we guidance quarter to half of and As the back that the time.

Chris Barry

one additional I story. And point, we just mean being this little second half a bit half, first talked about

and last case hurricane back the and after had given like into As got strong of going impact international XXXX, we the the or harder the side, we've of the on flipside, easier hardware strength year and we comps the U.S. year have in second side you QX comps really the on volumes guys half know favorable coming business, on QX from in the XXXX.

we've quarter second the And second more year. So optimistic be, of story. it's cautiously half all quarter, Chris go we this a bit the have and start as to balance first half a little a the bit said, of into a got we great like but

Kevin Farshchi

Thanks That question sense. makes guys. to on ton Wanted ask of a a quick Pulse.

you As launch without bit side, for that indications talk to product a the to? clinicians how just at a showed Robotics if year. beginning September same provide in customers present be then, color to talk from the some I and be either progress when some you to little the on in a about NASS from know you Robotics perspective could Can recognize showed it for you're Pulse add-on robot you're add-on, what may there? launch building And revenue can you're about the And bit you or that you the Robotics revenue look will going inevitably NASS you've presenting prototype like? at little indications the it, the may the this that

Chris Barry

back Yes, company, I'll systems launch Thanks from phase we're question. our give predictable alpha a We're that super support, be way boarder deliberate technology a shot. year, the before company now. to to half we coming customer going going can how mentioned I reproducible and very to the -- I to as drive Clearly, -- be be new we for of new think, walk and first we're run we're to into we the good tests run. to The about a moving integrated much We're trials and more sales. surgery. this company going honest, procedurally seen into this really our very entry reaction into the into thinking we've to is it in our we're of a to the really going before excited a have about

something -- the we’re demand, do learn of to, as look we sure I doing as of pre-selling To process. we lot -- into a don't think I as that third revenue we're I we And we for and don't earlier, And this speak. types very fourth learn and as a mentioned I year. going very strong -- need quarter. as showing products. we're end, into how is look demand make these that that quarter to that want As to the implement speak, material manage do I the we'll technology. showing us in the an organization company, to that's strong a to for But ton

robotic ultimately, modalities, case. multiple cases, technology. or technologies, be utilized on or our of environment system about system as Robotics our that into application of to What the to every I'm integrating think, to XD, having simplistically into. Pulse, we've reducing through a build exposure to imaging, Moving going supports be future over with Whether say focused very architectural in to is, Robotics, the and, going our Pulse to I features kind We that then navigation, a any -- on I in our system or technology, the broader surgery. XD a multiple future, We're speak spine robotic LessRay is Pulse to want software-rich of radiation and of application -- talked will benefits not Robotics. utilization

So I think think Robotics. it and we -- necessarily Pulse about don't about then

Pulse about and think Pulse then I with Robotics.

and into So Pulse support from that we're to launching of growth, seeing entering exceptional phase system. we're the been exposed reaction about the technology. this the this We're our have customers

we temptation organization, going than resist to an support. are As the can to move we what faster

NASS We September. in Pulse excited have capability. we're application an to organizationally to at our learn And our robotic system unveil to and build and enhancement

of and we see insight. and say disciplined we're level hold about the to So to be going hear hopefully I until see I'm going about Robotics, raises our guys anxious know what that in September. but you people to that are

Kevin Farshchi

so very Definitely you congrats Thank again. exciting. much and

Chris Barry

Appreciate the you. question. Thank

Operator

the proceed coming question Morgan Thank Instructions] from line with next Please of you. your Demchick will question. be Stanley. The with Jonathan [Operator

Jonathan Demchick

guess I talked the into leases, usage their? rate taking what's with follow-up this Hello. conversation. wanted out based on so to and From about revenue Thanks selling Pulse sales, Pulse far, or out robotics Pulse, plan secondly for just selling both of this guidance are I Just future, any hit strategy for from recognizing year. to they guidance for without wanted color the the also but and customers trying on question. you you've this looking Is models? kind of upside? about is with then to And to of more year the needed think revenue? figure any the how that

Matt Link

Kind need is We've of our reflected in question. our commitments. your to I -- don't don't what additional guidance, to first so capital or we the back deliver believe any we on sales

taking -- think focused in I anything to be company on order the directly we trying end. by think don't how we on where I'm being have a that sell I system. capital multiple how not take current we in want the really, customer to earlier, that a and I utilization. necessarily on being Pulse that with focused we hardware our hurdles I I an table the needs recognize today's want would mentioned And off systems-based technology not that to to become our as means how sell we inherently the system, the I we we that I'm the architecture do we're inclusive place limited thing represent utilization tell would would install. the Pulse to that knowledge we're open-minded in system, as of offer on robotics. in to tying system revenue and focused with see to with

that So technology I to to the We're learning ways innovative we as we the conversations technologies, I our mentioned very or we we drive as we're that with support do think to acquire and can having our said that open-minded. so product it technology. sell think we proper and before, with will the surgery. spine further other define And place best for customers customers, advanced the I think very get as them ways utilization different I strategic this how around are this being technology way

Operator

Thank of you. The Please Fargo. Biegelsen with question proceed with comes question. line the next Larry Wells your from

Larry Biegelsen

for and NuVasive. Good start taking afternoon. year a congrats Thanks to on and everyone the Chris good at question the

Matt Link

Larry. you, Thank

Larry Biegelsen

Could getting Chris understand there? you just have then you I price on opportunity premium? us XXXX. is First the one a follow-up. And question commercial Are help

Chris Barry

this so and Okay. I'm Matt. matt time for he take I’m here long going on worked Matt's expert going in let this to one. a our XXX let

Matt Link

good Larry, Hey, afternoon.

one space is for ability LX this history instances. XLIF address in SX to learned there in of in the well pathologies applications limitation defined the and fixation procedural that certain segment. that look over for require interbody both XLIF the patient is And of antibody is So may certain repositioning the requirement whether we've things to of relatively and become particular

And lateral so And has the being premier technique we still other in utility an comparable believe it XLIF in interbody in approach. in broader such year particular interbody – other it to and market makes that see goal. segment PLIF the minimally opportunity providing the the lateral a our to efficient surgery, interbody techniques invasive recapture as so, of the expand from technologies first doing a today been TLIF of manner particularly and

a greater the shifting, so then approach position and the based and a also on offer to to see the better share a but we And savings healthcare in as with solution cost primarily single interbody techniques efficiency offers patients ability respect to it setting.

really other the leader. market we that's what So lateral interbody to opportunities around market about the opportunity think shifting we XXXX where remain surgery

Larry Biegelsen

margins helpful. top a And NuVasive's growth lot. with picture big a That's very it just on suffered been versa. vice and Thanks question, line seems focused Chris, have

line both? is So questions. you, expansion? for question my Chris And do or your margin growth to what's priority taking is for it the top Thanks possible

Chris Barry

spine that's So, thanks And that's our growth is to continue innovative we at in one clearly top how company a technology reflection innovation on Larry. number of actually as a foremost I both. innovation I and direct want the first technology customers and answer think do it and truly possible of be priority value to and a Simple focus is to the space. day, will end line because the technology.

discipline. us a now – at drive the $X some my naturally way, is simply -- to priority. as but a markets. drive early customers we the one believe that is all across Having enterprise, more a we've billion. efficiencies over procedural move become do take it billion that, international our systems-based said, me to with along leverage, full I to grown, operational company growing possible there There is a advantage across way to function our as company, Clearly, which our little trade-offs to channels. is footprint believe -- said in So I as drive $X.X some from we efficient integration a continue think number of is I for of level there And to are of as

weeks you in that's it only I So said to back a in this is I The ago. one to I San of is few to question Francisco, innovative believe improvement. pace not opportunities rally don't we organization I galvanizing required. how XXX% which is possible, I I to arbitrary accomplish do believe but that drive the a operating thing say, want margin is would The objective. margin What trade expansion have. drive

also diligent the disciplined driver our innovate So and strive and to and continue to improvement be ensuring I that forward. margin will continue drive will on I across technology business, but we

we both. our we are but So to margin number wind one of that continue as priority. that to long really way saying of way we our something is is that do rate long – winded lead from perspective innovation the speak, an expansion assessing The going market and we're will

Raj Asarpota

path We bit If about Chris to expansion. more have for that not the Look, exist over opportunities changed. I saying of little margin can add just XXXX on levers a to said. the and years. what emphasize Those last talked couple color we've been

our and have. quite that international factory to continues move our said gross it's nicely it's efficiencies, that's leverage salesforce its whether we top continues along other So that, which company scale, investment Chris's balanced Having those operational pay on leverage again to margin, going line profit to dividends to as and of P&L. kind the there be point rolls are as think to margin how the drive through about we this will opportunities

Larry Biegelsen

Thank you, guys.

Chris Barry

Yeah. you for the Thank question.

Operator

with Our Richard with next the proceed question SVB question. is Leerink. of line from Newitter Please your

Richard Newitter

a points may just -- Hi, margin some appreciate thanks are for I there that better that of a investment guide. outperformance got with the were I thinking little line top XQ where off be are And the to were some wanted had gross in Raj, we there items quarter year margin XQ. where margins -- Street, reiterated certainly the The in started taking right the the pushed -- get the you basis questions. XQ about consensus some and that the about in and to first out. you understanding was, up stronger that where in full moving XQ, on specifically, you But still and XXX came think above year by remodeled

cadence relative the thinking kind in there? is of maybe The was? that modeling Street where guess the So carry-forward increase was no should line miss And -- is internal came a we if plan what just with question it, your get that's be Or trying I And through the saw? gross the outperformance given improvement to there we guidance that for margin I'm the outperformance? explanation this to

Raj Asarpota

Sure. Yeah.

expansion we we yeah, -- unpack was gross if the that about ended last performance to margin XX.X% of good. you from if think I you let saw. do me So XXX where basis -- think year So points at that, walk to right? try And

So that tells we had great performance.

I of there. throughput really quite growth up think we nicely. there months stable said have is The we turning seen six now

leverage XXX plans and basis West offset that good points margin, so royalty translates The you expansion We as know saw a bit -- of And of of XX expired services get would had basis expense little as Carrollton. And I saw goodness you in a that's from that top about a couple to have we in quarter. we through from we working, and on in-sourcing points NCS came you saw business through performance the fixed line products. so Our price. mix more cost that that. say

of points about mix. basis falls the then through the rest XX it was So and price erosion

So above U.S. and growth. was NCS core -- growth the about international the

year of through worked mentioned so kind that have out. And in up of slower. lot have that think the from those So that's we from what GM, in you gross performance. some last then streamlining margin we've that operating efforts little And margin margin the then mid outside we office gross drove script back We bit also there kind starting saw efficiencies have and the about have efficiencies working I a ramped that so continued a investments of fallout. as was been then, think

and first was packaging the quarter sterile year. we to MDR, the go little rest of up as a the in start slower will the through catch So bit the

are will point of long-winded that margin operating to our at maintaining guidance a we way that we saying I guess you So change, it's updated. continue and should this keep

Richard Newitter

to this I'm be one. little bit make exactly I'd to holistic of customers guys thought you sure Thanks. sure a a or other your company focused from talking transition hear you was mean just systems on from or I the procedural-focused because a to needs. the understanding procedural systems-focused on moving Okay. you a have may NuVasive away about when And clinical you itself of their and -- kind I focus? talk about company. do just approach means, in that procedure that a actual making a one systems want that focused what procedural What service

Chris Barry

to Let the moving overall our We're more procedural approach approach. me be clear. We're not enhancing from room actually away by procedural becoming operating infrastructure.

that other the staff many inclusive best theater possible possible talked we technology ensure a into procedures for room incorporate systems-based cases clinical is staff, moving ensure so environment, and Having evolution the cases fully procedural the our of navigation the our on procedure, possible will that and imaging. that we've the where the and we we've entire be participated. capabilities for support patient. system neuro part much providing associated that engaging equipping the with procedure the to have considered systems, now focus past we're surrounding be, We still hub but a So but by offering of we focus by more Pulse, in are technologies the integrate best many safest and within that and operated to start and into the have Pulse outcomes of robotic realm only training enhance to we'll to haven't a participating should this be company the just not room ultimately now to inherently going been to offering procedural monitoring outside hardware procedure. solutions the inclusive patient, Clearly what the integral operating operating what capabilities, next system our on by in the ultimately that safest and into are be driving we're XD physician the providing about the the integrating We're entering just now to the XD solution for procedural a of could not and It's surgeon or part in the interbodies, that start monitoring aspect solution. and LessRay the of patient. the possible which in what it participating of not

Richard Newitter

Thanks.

Chris Barry

That make good? that sense? Is

Richard Newitter

Thank you. you, thank

Chris Barry

you. All right. Thank

Operator

the with Please Suisse. next comes of from question. proceed line your Miksic The with Credit Matt question

Matt Miksic

Thanks.

This in make of I these for as down I from the given you So, substantial expenses some a in some And to QX pretty there’s timing and wanted normally sense the cadence then that should the call, guess QX. how margin had operating quick substantial. just little wanted step maybe forward slightly on much it operating going of And about a And of a to of historically on to of a like terms expect time lot you mentioned sure, of we variability, QX less one margins. folks of robotics. was the was cadence? get talk And just follow-up different early I timing just the be Raj to of expenses?

Chris Barry

Yeah.

accordingly. is rest will higher of slight half you're cadence, a a as that ramp to the SM&A expenses, margin up the of think than And of quarters the But right of little did and couple see be going a you'll will the I margin what we of year. so operating we see bit operating QX align the year. through -- back have next the So we are in margin typically your go in ramp operating operating

Matt Miksic

Okay.

just less a up about? like pattern, then substantial see a you're might substantial talking on step significant you the and in whereas, spending based QX maybe that step So, to QX QX ramp similar less

Raj Asarpota

That's right. about

Chris Barry

from seen save QX, have one to more you timers much sharp mean, so. would a I in QX for Yeah, QX, the drop

Matt Miksic

all And that quantify that? I sorry basis for if or of points at anything you I'm missed like those but help understand can did terms us it, that in

Raj Asarpota

In terms of...

Matt Miksic

XX it point been additional without basis of don't -- words, different the -- points have say another I basis basis points XXX to points basis would one margins XXX would XXX or know been Like have timers?

Raj Asarpota

it, think it's to you points XXX if basis basically. around going about -- right Its to be XXX

where billings Easter left Europe pick off. So last continue There from the again fell. There billing a side. and one Chris holiday some of there the year couple alluded to that was QX up to the beat that days collections were timing topline a we had in on how from the of timers on the extra

offset had had a to order expenses the we came we that some also are of out. than being packaging pushed distributor also in MDR and that sooner and We then sterile that expected

So points points. basis the XXX is ballpark XXX around basis

Matt Miksic

you that I And have helpful. in interested not dip company the would what of company, gone do two to on at other that players you not approach? degree of any observations and to learned? may hand we have Just thing team that’s chase lateral that capability that a us your and with that's should given tell the too sort down major don’t expect in and it, then but be you robotics of you know could From much a in we is lot Matt Got the robot, really something surgery, something in maybe bit or -- want that ask down, but this might but to speaking -- different more your Chris expecting not perhaps might you NAV? just be you're allowed point, all ahead unique folks field fair, what that's path, the not you and a I

Matt Link

we pride actually reference point. We're who portfolio a getting in a of that We component in our company are of technology. is great a foundational lateral, take being

in did excellent Pulse. what of ease we it workflow surgery. the value And value. that job in largely I seamlessly environment integrating incremental respect an adoption to a talking and think based by to is application provide see utility supports of the clinical the and to And improvement OR that with Chris is technology actually drives about needs

in about of represented best completely form trying out support think we as the rich And to way think so, building environment that's Pulse, what I mechanical robotics really a that application today. will clinical broad to market in do we're of automation applications don't this the believe the space. that is Its providing

Matt Miksic

Great, you. thank

Operator

proceed Wuensch Joanne question. Markets. BMO line The Please question with from next Capital with the of your is

Steve Plachtyna

Joanne. This is Steve for on

with what area and a of see guys XXXX standpoint portfolio question improved? outside the in coming feel from what areas biggest If and online portfolio is, spine Pulse. products would like You number of guess do I year you robotics, this gaps? to any, new the launch have the you

Chris Barry

of work of be just will restate kind market the me and looking Let to use this to grow. the

about, a got or It's get so including months. lateral just that over spine We've focused consider last or to invasive on outside surgery we now surgery a over lead lateral Surgery and be to enhancing in approaches admitted primary to we and single-position invasive in we noninvasive we As lot what of continuing area. focus side surgery is cervical, think talk focus the minimally to surgery to to minimally drive just I the this Lateral lot and this about think in continue that growth and across last I a innovation where factor developing cervical year. lot position to and there XX the we decade keep something line misrepresented of XX the like because has innovation reach has strong lead the enterprise. another everything with we're complex growth a technologies all deformity areas will areas But of of and in a spine plate

as player. So, starts competitive I think us reposition it spine a more broader

Those share. just down the starting internally and going we're going it. other fair but this look globalization to getting procedures much, just excited to our really across our NuVasive's -- we One pathway starting we're least moving very tremendous breadth support globalizing are way key for then building with the a just where proceeds obviously starting and don't are the start at are, this to full ultimately provides is advantage of And the And the strong we're businesses into to globe really the depth want in obviously, groundwork really about and spine that very better business the more for do we that and and but just should too opportunity we're we artificial lastly, customers settle And there. efforts more to but I at for equal about really how become us. providing but then of talking take drivers get the patients. underscore --

excited underrepresented really room we've to to room about most grow got So, minimally invasive We've the opportunity. the outside and we're of got grow the approach.

Steve Plachtyna

you And automated that XXXX in system Or the the I great. the international how global U.S., a on follow-up quick expect out know we Pulse ground just just the in event? mean more it's but it off should of launch? getting may Is for markets? Pulse. here Okay, rolling think I be about

Matt Link

Hi, Matt. this is

So, as typical think as and as clinical New when of and we're actually about second Europe as running Zealand. cycle, timing we earlier concurrently are launches as alpha well sales so really been we for and our commercialize year ability that's select Australia market was well that global testing in But in accounting Pulse bring stated introduction countries all believe important to the as entire XXXX, a consideration consistently certainly manner as a portfolio but do we full we and to half absolutely is well.

Steve Plachtyna

taking for Thanks the Great. question.

Chris Barry

you. Thank

Operator

your Zimmerman of with Ryan BTIG. with from comes the questions. next proceed The question Please line

Ryan Zimmerman

to taking the ask I the biologics of want first for All right, the stability great. question. Thanks about franchise.

specialists a they just out that called the lower-cost the recently. hired PBM. cell tend like And you down? to And either impact that accelerate those are stem is point have downshift as has been we what end sales It you whether really been market at I'm going And more You you this where at or couple more the wondering or the slow broadly of away sounds speaking, markets? market? is in that going effective

I that And is you. the quick then year? benefit in biologics on Thank the what of contract. what are have the us you one business? guidance? the And status the should a of help understand So, this status And contract factoring think the impact Premier about we follow-up a how just with

Chris Barry

first the maybe second, let take will Matt business. close take I'll he's the NCS one, to

seen So, being on Since think mix. player. although the increasing portfolio the now more you also a about a -- portfolio, were being broader price favorable gone offset broadening biologics, we've we where just high-end volumes were a we've as cycle or -- it, driving by through

as X% this growth negative XXXX quarter, should which basis For we compared but improvement, that's QX we we about of line go. an where were to is a example, with it XXX point think in

broadened leadership that and over franchise. foremost; We have strongly put portfolio. We’ve the we’ve first

We’re have specialists to sales not accelerate and sales around going through permanent an focus then our exhaustive process to added and recently gain better for attention more force capability organizational more biologics.

flat to to rest more about headwinds continue slight on annualize XX So that months last over months is those some annualize of market line headwinds, growth. as as course to really the we think the of we of this get of back the we year, took with which mix a growth we normalized in to we'll XX

track. we're So on

question Second on the… was

Raj Asarpota

contract. Premier

Chris Barry

…Premier contract.

turn me it let So over Matt. to

Matt Link

our plans factored organization and Just our the of real our premier in the this of field. second services in that focused on entered growth we've for businesses year and integration so half really we service into last the the of We're optimizing continuing this growth into year. services with the organization the utilization acquired contract quick really

consistent a growth continues our come a of strategy It through pipeline our a that. So online expectations. to of be opportunities seen we've and part Premier part with is

Ryan Zimmerman

Matt. you Thanks my question. Thank taking for

Chris Barry

you. Thank

Operator

Please proceed Thank question from JP is with you. with Morgan. The your of Marcus next Robbie question. line

Robbie Marcus

two just you question, for the ones posing Raj. quick To

second the then the the First, billing was here And U.S. cash was It How like were billing impact the on the there year-over-year. total was? flow. what's I've outside And outside billings but days two worth extra much question free days QX it my company U.S. U.S.? sounded on in of those down

cash planning instrumentation You then How over think for said there for? was do will following needed And year? what the about cash this flow in that's How three investment the what inventory. just your How be do some think much about quarters? to Thanks. with we follow flow you're we year? in do

Raj Asarpota

Yes.

first. So let question me start with the second

as had we in build in product So NCS with out collections quarter huge outside inventory that impacted bigger pointing introductions. our had which a of along was we -- business had you're that right factor we new or the associated that, the year -- But the with last do quarter XXXX, the the to free of -- year. for we our tend normalize the hitting the of that Having said over comparable the year, prior flow rest cash and they’ll targets growth go through we intend sorry, balance year.

into the So X% Was to for X.X% the first of bit impact yes, your we'll I And anomaly when an from days? remind two mean, quarter, the the your the days. regarding I be billing it. the a it -- for in question it me right question. billing Europe international there was Europe, to can first about you came back growth first was So think business of impact extra jumping but part

aren't these an regions, did mean, impact. numbers nonetheless but they within the huge have I So

at it's all the but over company So material. level, not

Robbie Marcus

you. Thank

Raj Asarpota

Yes.

Operator

no questions call back I to time. are comments. further the there turn at to Barry, like Mr. this for would closing

Chris Barry

Thank those forward to we look thank you. next in quarter. the that today. And with call Thanks. on you for speaking with the And you

Operator

This today's concludes conference. you. Thank

You may you disconnect your lines at time. this Thank participation. your for

Nuvasive (NUVA) 1 May 192019 Q1 Earnings call transcript